HomeTXMD • NASDAQ
add
TherapeuticsMD Inc
Previous close
$1.46
Day range
$1.42 - $1.52
Year range
$0.70 - $2.44
Market cap
17.36M USD
Avg Volume
40.89K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 393.00K | 25.56% |
Operating expense | 1.18M | -19.18% |
Net income | -653.00K | 11.04% |
Net profit margin | -166.16 | 29.14% |
Earnings per share | — | — |
EBITDA | -688.00K | 31.81% |
Effective tax rate | 4.79% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 5.74M | 32.43% |
Total assets | 38.24M | -9.15% |
Total liabilities | 11.50M | -14.36% |
Total equity | 26.74M | — |
Shares outstanding | 11.57M | — |
Price to book | 0.63 | — |
Return on assets | -5.08% | — |
Return on capital | -5.82% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -653.00K | 11.04% |
Cash from operations | 686.00K | 6,136.36% |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | 686.00K | 6,136.36% |
Free cash flow | 1.25M | 314.07% |
About
Founded
1907
Headquarters
Website
Employees
1
